PE20210322A1 - Composiciones que comprenden microbiota coseleccionada y metodos para su uso - Google Patents

Composiciones que comprenden microbiota coseleccionada y metodos para su uso

Info

Publication number
PE20210322A1
PE20210322A1 PE2020000909A PE2020000909A PE20210322A1 PE 20210322 A1 PE20210322 A1 PE 20210322A1 PE 2020000909 A PE2020000909 A PE 2020000909A PE 2020000909 A PE2020000909 A PE 2020000909A PE 20210322 A1 PE20210322 A1 PE 20210322A1
Authority
PE
Peru
Prior art keywords
dysbiosis
methods
microbiota
disorders associated
treatment
Prior art date
Application number
PE2020000909A
Other languages
English (en)
Inventor
Emma Allen-Vercoe
Original Assignee
Nubiyota Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nubiyota Llc filed Critical Nubiyota Llc
Publication of PE20210322A1 publication Critical patent/PE20210322A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se describen en la presente composiciones anhidras que comprenden una microbiota coseleccionada y metodos para utilizarlas para el tratamiento de trastornos asociados con la disbiosis (desequilibrio de la comunidad microbiana que habita un sujeto o habita un tejido particular de un sujeto). En particular, se contemplan composiciones anhidras que comprenden una microbiota coseleccionada y metodos para el tratamiento de trastornos gastrointestinales asociados con la disbiosis. Tambien se contempla en la presente el uso de estas composiciones anhidras que comprenden una microbiota coseleccionada para el tratamiento de trastornos asociados con la disbiosis (por ejemplo, trastornos gastrointestinales asociados con la disbiosis) y el uso de dichas composiciones anhidras que comprenden microbiota coseleccionada en la preparacion de un medicamento para el tratamiento de trastornos asociados con la disbiosis (por ejemplo, trastornos gastrointestinales asociados con la disbiosis)
PE2020000909A 2018-01-05 2019-01-04 Composiciones que comprenden microbiota coseleccionada y metodos para su uso PE20210322A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862614151P 2018-01-05 2018-01-05
US201862683850P 2018-06-12 2018-06-12
PCT/US2019/012376 WO2019136269A1 (en) 2018-01-05 2019-01-04 Compositions comprising co-selected microbiota and methods for use thereof

Publications (1)

Publication Number Publication Date
PE20210322A1 true PE20210322A1 (es) 2021-02-18

Family

ID=67144333

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2020000909A PE20210322A1 (es) 2018-01-05 2019-01-04 Composiciones que comprenden microbiota coseleccionada y metodos para su uso

Country Status (18)

Country Link
US (1) US20210069262A1 (es)
EP (1) EP3735224A4 (es)
JP (1) JP2021509904A (es)
KR (1) KR20200136365A (es)
CN (1) CN112087998A (es)
AU (2) AU2019205296B2 (es)
BR (1) BR112020013712A2 (es)
CA (1) CA3087695C (es)
CL (1) CL2020001783A1 (es)
CO (1) CO2020009670A2 (es)
EC (1) ECSP20046307A (es)
IL (1) IL275791A (es)
MX (1) MX2020007040A (es)
PE (1) PE20210322A1 (es)
PH (1) PH12020551038A1 (es)
SG (1) SG11202006450VA (es)
WO (1) WO2019136269A1 (es)
ZA (1) ZA202004678B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3773645A4 (en) 2018-04-10 2021-11-24 Siolta Therapeutics, Inc. MICROBIAL CONSORTIA
JP2022541278A (ja) * 2019-07-19 2022-09-22 フィンチ セラピューティクス ホールディングス エルエルシー 胃腸障害の治療のための方法および産物
JP2022551201A (ja) 2019-10-07 2022-12-07 シオルタ・セラピューティクス，インコーポレイテッド 治療用医薬組成物
WO2021138562A1 (en) * 2019-12-31 2021-07-08 Assembly Biosciences, Inc. Compositions comprising bacterial species and methods related thereto
WO2021145458A1 (ja) * 2020-01-16 2021-07-22 学校法人慶應義塾 胆汁酸を生成するための組成物
EP4132289A4 (en) * 2020-04-07 2024-05-15 The National Institute for Biotechnology in the Negev Ltd. PROCESSES FOR IMPROVING THE HEALTH OF YOUNG RUMINANTS
GB202007452D0 (en) * 2020-05-19 2020-07-01 Microbiotica Ltd Threrapeutic bacterial composition
KR102169794B1 (ko) * 2020-06-24 2020-10-27 주식회사 엔테로바이옴 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도
GB202015687D0 (en) * 2020-10-02 2020-11-18 Microbiotica Ltd Therapeutic composition
WO2022081428A1 (en) * 2020-10-16 2022-04-21 Nubiyota Llc Bacterial compositions and methods of use thereof for treatment of metabolic syndrome
CA3198416A1 (en) * 2020-10-21 2022-04-28 Gusto Global, Llc Microbial-based compositions for systemic inflammation control
AU2022272332A1 (en) * 2021-05-10 2024-01-04 Microba Ip Pty Ltd Compositions and methods for treating disease
AU2022388943A1 (en) * 2021-11-22 2024-06-06 International N&H Denmark Aps Compositions for metabolic health

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100330151A1 (en) * 2009-06-25 2010-12-30 Mary Elaine Freeland Method of Promoting Gastrointestinal Health Using a Combination of a Probiotic Microorganism and Chocolate
US20150374761A1 (en) * 2011-03-09 2015-12-31 Regents Of The University Of Minnesota Freeze dried fecal microbiota for use in fecal microbial transplantation
CA2848757C (en) * 2011-09-14 2021-11-09 University Of Guelph Methods to culture human gastrointestinal microorganisms
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
WO2014153194A2 (en) * 2013-03-14 2014-09-25 Seres Health, Inc. Methods for pathogen detection and enrichment from materials and compositions
US9511099B2 (en) 2013-06-05 2016-12-06 Rebiotix, Inc. Microbiota restoration therapy (MRT), compositions and methods of manufacture
WO2015013214A2 (en) * 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment
RU2736823C2 (ru) * 2014-07-01 2020-11-20 ПРОБИ ЮЭсЭй, ИНК. Двухслойные таблетки, содержащие пробиотики, с двойным высвобождением
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
EP3341472A4 (en) * 2015-08-24 2019-03-27 Nubyiota LLC SYSTEM AND METHOD FOR ENRICHING A BACTERIAL STRAIN FROM A TARGET BACTERIA SYSTEM
MX2019009861A (es) * 2017-02-23 2020-07-14 Intercept Pharmaceuticals Inc Composiciones farmaceuticas de un derivado de acido biliar y microbioma y usos de las mismas.

Also Published As

Publication number Publication date
AU2019205296A1 (en) 2020-08-13
EP3735224A1 (en) 2020-11-11
KR20200136365A (ko) 2020-12-07
MX2020007040A (es) 2020-11-11
AU2019205296B2 (en) 2021-12-23
CA3087695C (en) 2023-08-22
CN112087998A (zh) 2020-12-15
AU2022201981A1 (en) 2022-04-21
US20210069262A1 (en) 2021-03-11
WO2019136269A1 (en) 2019-07-11
JP2021509904A (ja) 2021-04-08
EP3735224A4 (en) 2021-11-03
CL2020001783A1 (es) 2021-01-08
PH12020551038A1 (en) 2021-09-06
CO2020009670A2 (es) 2020-08-31
SG11202006450VA (en) 2020-08-28
BR112020013712A2 (pt) 2020-12-01
IL275791A (en) 2020-08-31
ECSP20046307A (es) 2021-03-31
CA3087695A1 (en) 2019-07-11
ZA202004678B (en) 2021-09-29

Similar Documents

Publication Publication Date Title
PE20210322A1 (es) Composiciones que comprenden microbiota coseleccionada y metodos para su uso
BR112022010349A2 (pt) Compostos bifuncionais para degradar btk por meio de via da ubiquitina-proteossoma
CO2017004525A2 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
MX2020012602A (es) Composiciones bacterianas dise?adas y usos de las mismas.
EP4374851A3 (en) Ophthalmic composition for treatment of dry eye disease
CL2021000415A1 (es) Vesículas derivadas de lactobacillus paracasei y uso de las mismas
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
BR112016028961A8 (pt) fibras eletrotorcidas, seu método de preparação e seu uso, bem como composição, e kit
EP3616716A3 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
MX2016012574A (es) Compuestos heteroarilo sustituidos y metodos de uso.
CL2017003152A1 (es) Composiciones de hidroxipropil beta-ciclodextrina y métodos
CL2015002835A1 (es) Nuevos derivados de piridina
DOP2016000102A (es) (aza)piridopirazolopirimidinonas e indazolopirimidinonas y su uso
MX2016014564A (es) Vacuna contra la acinetobacter baumannii obtenida a partir de componentes celulares carentes de lipopolisacarido.
AR106385A1 (es) Composición cosmética que comprende bacterias probióticas
NZ732241A (en) A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
CY1123366T1 (el) Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου
BR112017009510A2 (pt) composições compreendendo ciclosporina
MX2020012800A (es) Cannabinoides y usos de los mismos.
EA201891337A3 (ru) Фармацевтическая композиция от нейропатической боли
DOP2016000297A (es) Composiciones farmacéuticas útiles para tratar enfermedades infecciosas
WO2015106215A3 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
BR112017022755A2 (pt) formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof